MLTX · MoonLake Immunotherapeutics
$16.74
+0.40 (+2.45%)
At close · Aug 19
Market Cap
$1.39B
Shares
85.11M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-08-31 | — | $350,000,000 | $213,800,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-10 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2024-12-31 | $50 | 10-K, filed 2025-02-26 | ||
Key facts
CIK
1821586
CUSIP
61559X104
13F (30d)
173 filings
167 filers
Visit website
Investor relations